The Benchmark Company downgraded Select Medical from Buy to Hold
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/13/2026 | $16.50 | Outperform → Neutral | Mizuho |
| 3/3/2026 | $16.50 | Outperform → Sector Perform | RBC Capital Mkts |
| 10/8/2025 | $16.00 → $20.00 | Outperform | RBC Capital Mkts |
| 4/16/2025 | $25.00 | Outperform | Mizuho |
| 2/24/2025 | $23.00 | Hold → Buy | The Benchmark Company |
| 11/25/2024 | Buy → Hold | The Benchmark Company | |
| 8/20/2024 | $42.00 | Buy | BofA Securities |
| 3/7/2022 | $47.00 → $42.00 | Outperform | RBC Capital |
Mizuho downgraded Select Medical from Outperform to Neutral and set a new price target of $16.50
RBC Capital Mkts downgraded Select Medical from Outperform to Sector Perform and set a new price target of $16.50
RBC Capital Mkts reiterated coverage of Select Medical with a rating of Outperform and set a new price target of $20.00 from $16.00 previously
MECHANICSBURG, Pa., June 30, 2026 /PRNewswire/ -- Select Medical Holdings Corporation (the "Company" or "Select Medical," "we," "us," or "our") (NYSE:SEM) today announced the completion of its acquisition by an entity affiliated with a consortium led by Robert A. Ortenzio, Executive Chairman, Co-Founder and Director of Select Medical, Martin F. Jackson, Senior Executive Vice President of Strategic Finance and Operations of Select Medical, and Welsh, Carson, Anderson & Stowe ("WCAS" and, together with Mr. Ortenzio and Mr. Jackson, the "Consortium") pursuant to the terms of the Agreement and Plan of Merger, dated as of March 2, 2026 (the "Merger Agreement"). The previously announced purchase p
NEW YORK, June 26, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600: Gulfport Energy Corp. (NYSE:GPOR) will replace Select Medical Holdings Corp. (NYSE:SEM) effective prior to the opening of trading on Wednesday, July 1. Select Medical Holdings is being acquired in a deal expected to be completed soon, pending final closing conditions.Mobility Global Inc. (NYSE:MBGL) will replace Core Laboratories Inc. (NYSE:CLB) effective prior to the opening of trading on Thursday, July 2. S&P 500 constituent S&P Global Inc. (NYSE:SPGI) is spinning off Mobility Global in a transaction expected to be completed July 1. Core Laboratories is no longer represen
MECHANICSBURG, Pa., June 26, 2026 /PRNewswire/ -- Select Medical Holdings Corporation (NYSE:SEM) ("Select Medical," "we," "us," or "our") confirmed today that its previously announced Agreement and Plan of Merger (the "Merger Agreement," and the transaction contemplated thereby, the "Merger") with an entity affiliated with a consortium led by Robert A. Ortenzio, Executive Chairman, Co-Founder and Director of Select Medical, Martin F. Jackson, Senior Executive Vice President of Strategic Finance and Operations of Select Medical, and Welsh, Carson, Anderson & Stowe ("WCAS" and, together with Mr. Ortenzio and Mr. Jackson, the "Consortium") was approved at a special meeting of Select Medical's s
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
15-12G - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)
25-NSE - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
SCHEDULE 13D/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
NEW YORK, June 26, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600: Gulfport Energy Corp. (NYSE:GPOR) will replace Select Medical Holdings Corp. (NYSE:SEM) effective prior to the opening of trading on Wednesday, July 1. Select Medical Holdings is being acquired in a deal expected to be completed soon, pending final closing conditions.Mobility Global Inc. (NYSE:MBGL) will replace Core Laboratories Inc. (NYSE:CLB) effective prior to the opening of trading on Thursday, July 2. S&P 500 constituent S&P Global Inc. (NYSE:SPGI) is spinning off Mobility Global in a transaction expected to be completed July 1. Core Laboratories is no longer represen
MECHANICSBURG, Pa., Sept. 2, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) today announced the appointment of Thomas P. Mullin as its chief executive officer. David S. Chernow, who has held the position since 2014, has been appointed vice chairman of the board. John A. Saich, who most recently held the position of co-president, will serve as the company's sole president. John F. Duggan has been appointed executive vice president, general counsel and secretary. The appointments are effective immediately. Mr. Mullin joined Select Medical in 2008, most recently serving as co-president overseeing 140 critical illness recovery and inpatient rehabilita
NEW YORK, Nov. 19, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Flex Ltd (NASD: FLEX) will replace Azenta Inc. (NASD: AZTA) in the S&P MidCap 400, and Azenta will replace Envestnet Inc. (NYSE:ENV) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, November 25. Bain Capital is acquiring Envestnet in a deal expected to be completed soon, pending final closing conditions. Azenta's market capitalization is no longer representative of the mid-cap market space.Concentra Group Holdings Inc. (NYSE:CON) will replace Myers Industries Inc. (NYSE:MYE) in the S&P SmallCap 600 effective prior to the openin
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
MECHANICSBURG, Pa., April 30, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced results for its first quarter ended March 31, 2026, and the declaration of a cash dividend. For the first quarter ended March 31, 2026, revenue increased 5.0% to $1,421.5 million, compared to $1,353.2 million for the same quarter, prior year. Income from operations was $98.4 million for the first quarter ended March 31, 2026, compared to $112.7 million for the same quarter, prior year. Net income was $63.8 million for the first quarter ended March 31, 2026, compared to $74.7 million for the same quarter, prior year. Adjusted EBITDA was $14
MECHANICSBURG, Pa., April 9, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM), will release the financial results for its first quarter ended March 31, 2026 on Thursday, April 30, 2026 after the market closes. Select Medical will host a conference call regarding its first quarter results, as well as its business outlook, on Friday, May 1, 2026, at 9:00am ET. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call through the same link.For listeners wishin
MECHANICSBURG, Pa., Feb. 19, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced results for its fourth quarter and year ended December 31, 2025, its 2026 business outlook, and the declaration of a cash dividend. For the fourth quarter ended December 31, 2025, revenue increased 6.4% to $1,396.6 million, compared to $1,312.6 million for the same quarter, prior year. Income from continuing operations before other income and expense increased 203.1% to $63.9 million for the fourth quarter ended December 31, 2025, compared to $21.1 million for the same quarter, prior year. Income from continuing operations, net of tax, incr